Genetic links between migraine and blood sugar levels confirmed Dr. Kamal Kant Kohli16 March 2023 2:30 PM GMTIn a study published in Human Genetics, QUT Professor Dale Nyholt and QUT PhD researcher Rafiqul Islam, describe using large-scale genome-wide...
Expert Doctor On Causes Of Migraine - Dr Nikunj Mittal Dr Nikunj Mittal24 Feb 2023 11:04 AM GMTMigraine is one of the most prevalent types of headaches reportedly affecting 213 million people in India in one year and 60% of cases of migraine...
Higher intake of dietary zinc tied to lower risk of migraine, study reveals Medha Baranwal24 Jan 2023 2:30 PM GMTChina: A recent study published in Headache, The Journal of Head and Face Pain suggested an inverse association between dietary zinc intake and...
FDA approves first rescue treatment of asthma for adults Dr. Kamal Kant Kohli13 Jan 2023 2:30 PM GMTThe US Food and Drug Administration (FDA) has approved albuterol/budesonide (Airsupra) for prevention and treatment of bronchoconstriction and to...
Dr Reddy's Labs, Theranica collaborate for commercialisation of wearable migraine treatment Nerivio in India Ruchika Sharma12 Jan 2023 7:06 AM GMTNerivio is the FDA-cleared, prescribed, digitally connected, drug-free wearable device for the acute treatment of episodic and chronic migraine in...
Rocatinlimab shows promising long-term results for Moderate to Severe Atopic Dermatitis: Lancet Dr. Kamal Kant Kohli12 Dec 2022 5:15 AM GMTRocatinlimab is a novel, patient-tailored monoclonal antibody therapy. Role of rocatinlimab as a safe and effective treatment for atopic...
Esketamine nasal spray found superior to quetiapine extended-release in resistant depression in phase 3 trial Dr. Kamal Kant Kohli30 Nov 2022 2:30 PM GMTEsketamine nasal spray was found superior to to quetiapine extended-release (XR) in adults with treatment-resistant major depressive disorder,...
MRI reveals significant brain abnormalities post-COVID upto six months Dr. Kamal Kant Kohli21 Nov 2022 2:30 PM GMTResearchers have uncovered brain changes in patients up to six months after they recovered from COVID-19, by using a special type of MRI.The study is...
Prevalence of Trigger Factors and Associated Disorders in Tension-type Headache Dr. Nandita Mohan12 Nov 2022 4:00 AM GMTHeadache is most common pain suffered by many. Tension-type headache is the most common primary headache disorder. As per the Global Burden of...
Fezolinetant safe and effective treatment for VMS associated with menopause: Phase 3 SKYLIGHT trial Dr. Kamal Kant Kohli19 Oct 2022 6:45 AM GMTUSA: According to data presented at the NAMS Annual Meeting, women using fezolinetant for moderate to severe vasomotor symptoms experienced a...
Cognitive Behavioral Therapy significantly reduces headache disability, PTSD following brain injury Dr. Kamal Kant Kohli6 July 2022 3:30 AM GMTSAN ANTONIO: Cognitive Behavioral Therapy is the first therapy to be developed specifically for post-traumatic headache that may significantly reduce...
Top Medical Bulletin 29/Jund/2022 Dr. Nandita Mohan29 Jun 2022 12:00 PM GMTHere are the top medical stories for today:New therapy to reduce Headache, PTSD following brain injury Effective treatments exist...
